Pharmacy to overload stocks with non-reimbursable drugs

Published: 2002-01-28 06:57:00

Updated: 2002-01-28 06:57:00

As a result of rescheduling other non-prescription drugs such as digestive enzyme preparations to a non-NHI reimbursement effective from April this year, every pharmacy may face with a stock overload in the amount of 500 to 1,000 thousand won on average, thus giving a heavy inventory burden to th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK